<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2146">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on September 19, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01847027</url>
  </required_header>
  <id_info>
    <org_study_id>2012-162</org_study_id>
    <nct_id>NCT01847027</nct_id>
  </id_info>
  <brief_title>Exercise and NutraStem (NT-020): Effects on Stem Cells</brief_title>
  <official_title>Phase 2 Study of the Effect of a Nutritional Supplement and Exercise on Human Stem Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Texas Health Science Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of South Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Texas Health Science Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to see if an investigational supplement called NutraStem® will&#xD;
      increase the amount of stem cells in human blood at rest and after exercise. The ingredients&#xD;
      found in NutraStem® can be found in nutrition or vitamin shops/stores.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized double blinded placebo controlled trial of a nutraceutical preparation. Up to 60&#xD;
      men and women between the ages of 50 and 70, and generally healthy will participate in this&#xD;
      study. . Up to 30 participants will receive the nutritional supplement and up to 30 will&#xD;
      receive placebo.&#xD;
&#xD;
      Potential participants will be screened by telephone and have the study explained to them in&#xD;
      detail. If they qualify and choose to participate they will come in for the first of three&#xD;
      visits. Informed consent will be obtained and demographic information collected. Information&#xD;
      requested on the demographic form includes ethnicity, income, education, marital status,&#xD;
      smoking and alcohol use, and exercise habits. Next they will have blood pressure checked and&#xD;
      if not within parameters they will be dropped from the study and informed that they need to&#xD;
      follow up the abnormal result with their health care provider. Those that pass these&#xD;
      screening tests will have 15 to 25 cc's of peripheral blood (serum) collected by the study&#xD;
      coordinator via venipuncture while at rest. They will then stretch for 2 minutes (60 seconds&#xD;
      marching in place followed by 10 toe touches) followed by accelerating treadmill walking&#xD;
      exercise. The exercise intervention will consist of a 15 minute period of walking on a&#xD;
      treadmill. The treadmill will not be inclined during the intervention. The participants&#xD;
      target heart rate will be determined by deducting their age from 220. They will start walking&#xD;
      on the treadmill at a speed of 1.7 mph and the speed will be titrated as indicated to keep&#xD;
      their heart rate at 50 to 90% of target. Heart rate will be monitored via the pulse oximetry&#xD;
      feature of the Welch Allyn vital signs monitor. Blood pressure will be measured every 3&#xD;
      minutes during the exercise intervention and until they have returned to baseline (within 10&#xD;
      points) following cessation of the exercise protocol. The test will be stopped for any&#xD;
      participant complaint of chest pain, excess fatigue, difficulty breathing, a blood pressure&#xD;
      reading of more than 180/94, or a participant request. If symptoms increase or do not&#xD;
      completely resolve with 15 minutes of rest the study coordinator will call 911 (through&#xD;
      campus police) to activate the EMS response. If symptoms resolve completely within 15 minutes&#xD;
      participants will be withdrawn from the study and advised to follow up with their health care&#xD;
      provider. Any participant unable to complete the exercise intervention for any reason will be&#xD;
      withdrawn from the study.&#xD;
&#xD;
      Five to fifteen minutes after the exercise intervention has been completed blood will again&#xD;
      be collected in exactly the same manner as the resting sample. Participants will then receive&#xD;
      a 2 week supply of either NutraStem or placebo and will be advised to take one tablet every&#xD;
      morning and evening before meals for the next 2 weeks. If the participant is unable to&#xD;
      complete any portion of the visit activities at any visit they will be withdrawn from the&#xD;
      study due to their inability to complete the study. All visit activities will be recorded in&#xD;
      detail on the visit session record.&#xD;
&#xD;
      The second visit will occur 2 weeks later and include a blood pressure check, an at rest&#xD;
      blood draw, the exercise intervention, and then a repeat blood draw five to fifteen minutes&#xD;
      after completion of the intervention. Participants will then receive a 2 week supply of&#xD;
      either NutraStem or placebo and will be advised to take one tablet every morning and evening&#xD;
      before meals for the next 2 weeks. I Participants will be advised to bring their empty pill&#xD;
      containers to their next session so we can confirm they are taking the supplement as&#xD;
      required. If the blood pressure is outside of the specified range they will be dropped from&#xD;
      the study and no blood collection or study intervention will take place.&#xD;
&#xD;
      The third visit will be the same as the second visit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2013</start_date>
  <completion_date type="Actual">July 17, 2017</completion_date>
  <primary_completion_date type="Actual">July 17, 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of CD133+ Cells</measure>
    <time_frame>Baseline, 2 weeks, 4 weeks</time_frame>
    <description>The percentage of CD133+ cells detected in blood samples</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent of CD34+ Cells</measure>
    <time_frame>Baseline, 2 weeks, 4 weeks</time_frame>
    <description>Percent of CD34+ cells detected in blood samples</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Markers of Oxidative Stress</measure>
    <time_frame>Baseline, 4 weeks</time_frame>
    <description>Blood levels of C reactive protein</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Adult Stem Cell Proliferation</condition>
  <arm_group>
    <arm_group_label>Active supplement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>NutraStem, 2 tablets daily, Vitamin D3 (2000 IU), BioVin® (40 mg) and the proprietary blend (900mg).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sugar pill</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo is identical in appearance to the NutraStem® supplement and contains the following ingredients in a Vegi Capsule:&#xD;
MCC200 DICALCIUM PHOSPHATE BROWN LAKE BLEND (SENSIENT # 09127 ) RED DYE DB-088 (COLORCON) MAGNESIUM STEARATE BLUE #1 ALUM LAKE (POWDER)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NutraStem</intervention_name>
    <description>Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.&#xD;
Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
    <arm_group_label>Active supplement</arm_group_label>
    <other_name>NT-020</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
    <arm_group_label>Sugar pill</arm_group_label>
    <other_name>Sugar pill</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy men and women&#xD;
&#xD;
          -  Age 50 to 70 years old&#xD;
&#xD;
          -  Ability to walk on a treadmill for 15 minutes.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age less than 50 or greater than 70 years of age.&#xD;
&#xD;
          -  A history of difficult veins/difficulty obtaining blood samples&#xD;
&#xD;
          -  Unwilling to follow the procedures of the trial&#xD;
&#xD;
          -  Participated in more than 2 sessions per week of strenuous exercise in the last month&#xD;
&#xD;
          -  Unable to tolerate the ingredients in NutraStem® or placebo, or have food allergies&#xD;
&#xD;
          -  Intentionally lost or gained 10 or more pounds of body weight in the last 3 months&#xD;
&#xD;
          -  Acute illness&#xD;
&#xD;
          -  Severe co-morbid disease&#xD;
&#xD;
          -  Use of any prescription or non-prescription products for antioxidant regimen or stem&#xD;
             cell supplement within the past 4 weeks&#xD;
&#xD;
          -  Diabetic&#xD;
&#xD;
          -  Uncontrolled hypertension&#xD;
&#xD;
          -  Recent cardiovascular event (past 36 months), or a family history of sudden death or&#xD;
             heart attacks before the age of 55&#xD;
&#xD;
          -  Body Mass Index (BMI) of less than 20 or greater than 35 m/kg2;&#xD;
&#xD;
          -  Participated in a clinical trial in the past 4 weeks&#xD;
&#xD;
          -  Take methadone, insulin, anticoagulants (blood thinners), MAO's or similar medications&#xD;
&#xD;
          -  Anticipate the need for surgery of any type during the entire study;&#xD;
&#xD;
          -  Plan to donate blood or blood products during the study or for thirty (30) days&#xD;
             following the study&#xD;
&#xD;
          -  Active peptic ulcer disease or reliable history of gastrointestinal bleeding within&#xD;
             the past five (5) years&#xD;
&#xD;
          -  Recurrent or a history of intestinal disorders that may interfere with the absorption&#xD;
             of the product&#xD;
&#xD;
          -  Any disease or condition that in the investigator's opinion compromises the integrity&#xD;
             of the clinical trial or the safety of the subject&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meharvan Singh, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Texas Health Science Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of North Texas Health Science Center - Center for Biohealth</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76107</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 1, 2013</study_first_submitted>
  <study_first_submitted_qc>May 3, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 6, 2013</study_first_posted>
  <results_first_submitted>December 21, 2018</results_first_submitted>
  <results_first_submitted_qc>May 8, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 29, 2019</results_first_posted>
  <last_update_submitted>May 8, 2019</last_update_submitted>
  <last_update_submitted_qc>May 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of North Texas Health Science Center</investigator_affiliation>
    <investigator_full_name>Meharvan Singh</investigator_full_name>
    <investigator_title>Professor, Department of Pharmacology and Neuroscience</investigator_title>
  </responsible_party>
  <keyword>Healthy</keyword>
  <keyword>Stem cells</keyword>
  <keyword>Aging</keyword>
  <keyword>Increase stem cell replacement</keyword>
  <keyword>decreased stem cell proliferation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 4, 2013</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/27/NCT01847027/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Active Supplement</title>
          <description>NutraStem, 2 tablets daily, Vitamin D3 (2000 IU), BioVin® (40 mg) and the proprietary blend (900mg).&#xD;
NutraStem: Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.&#xD;
Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
        </group>
        <group group_id="P2">
          <title>Sugar Pill</title>
          <description>The placebo is identical in appearance to the NutraStem® supplement and contains the following ingredients in a Vegi Capsule:&#xD;
MCC200 DICALCIUM PHOSPHATE BROWN LAKE BLEND (SENSIENT # 09127 ) RED DYE DB-088 (COLORCON) MAGNESIUM STEARATE BLUE #1 ALUM LAKE (POWDER)&#xD;
Placebo: Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Active Supplement</title>
          <description>NutraStem, 2 tablets daily, Vitamin D3 (2000 IU), BioVin® (40 mg) and the proprietary blend (900mg).&#xD;
NutraStem: Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.&#xD;
Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
        </group>
        <group group_id="B2">
          <title>Sugar Pill</title>
          <description>The placebo is identical in appearance to the NutraStem® supplement and contains the following ingredients in a Vegi Capsule:&#xD;
MCC200 DICALCIUM PHOSPHATE BROWN LAKE BLEND (SENSIENT # 09127 ) RED DYE DB-088 (COLORCON) MAGNESIUM STEARATE BLUE #1 ALUM LAKE (POWDER)&#xD;
Placebo: Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="11"/>
            <count group_id="B2" value="12"/>
            <count group_id="B3" value="23"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58.5" spread="6.3"/>
                    <measurement group_id="B2" value="59.5" spread="6.1"/>
                    <measurement group_id="B3" value="59.0" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percentage of CD133+ Cells</title>
        <description>The percentage of CD133+ cells detected in blood samples</description>
        <time_frame>Baseline, 2 weeks, 4 weeks</time_frame>
        <population>subjects who completed all three visits and from whom blood draws were obtained</population>
        <group_list>
          <group group_id="O1">
            <title>Active Supplement</title>
            <description>NutraStem, 2 tablets daily, Vitamin D3 (2000 IU), BioVin® (40 mg) and the proprietary blend (900mg).&#xD;
NutraStem: Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.&#xD;
Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
          </group>
          <group group_id="O2">
            <title>Sugar Pill</title>
            <description>The placebo is identical in appearance to the NutraStem® supplement and contains the following ingredients in a Vegi Capsule:&#xD;
MCC200 DICALCIUM PHOSPHATE BROWN LAKE BLEND (SENSIENT # 09127 ) RED DYE DB-088 (COLORCON) MAGNESIUM STEARATE BLUE #1 ALUM LAKE (POWDER)&#xD;
Placebo: Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of CD133+ Cells</title>
          <description>The percentage of CD133+ cells detected in blood samples</description>
          <population>subjects who completed all three visits and from whom blood draws were obtained</population>
          <units>percent of total</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (visit 1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.50" spread="0.39"/>
                    <measurement group_id="O2" value="0.28" spread="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks (visit 2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.54" spread="0.49"/>
                    <measurement group_id="O2" value="0.47" spread="0.54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks (visit 3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.37" spread="0.25"/>
                    <measurement group_id="O2" value="0.35" spread="0.27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percent of CD34+ Cells</title>
        <description>Percent of CD34+ cells detected in blood samples</description>
        <time_frame>Baseline, 2 weeks, 4 weeks</time_frame>
        <population>Subjects who completed all three visit and from whom blood draws were successful</population>
        <group_list>
          <group group_id="O1">
            <title>Active Supplement</title>
            <description>NutraStem, 2 tablets daily, Vitamin D3 (2000 IU), BioVin® (40 mg) and the proprietary blend (900mg).&#xD;
NutraStem: Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.&#xD;
Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
          </group>
          <group group_id="O2">
            <title>Sugar Pill</title>
            <description>The placebo is identical in appearance to the NutraStem® supplement and contains the following ingredients in a Vegi Capsule:&#xD;
MCC200 DICALCIUM PHOSPHATE BROWN LAKE BLEND (SENSIENT # 09127 ) RED DYE DB-088 (COLORCON) MAGNESIUM STEARATE BLUE #1 ALUM LAKE (POWDER)&#xD;
Placebo: Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent of CD34+ Cells</title>
          <description>Percent of CD34+ cells detected in blood samples</description>
          <population>Subjects who completed all three visit and from whom blood draws were successful</population>
          <units>percent of total</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (visit 1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.46" spread="6.98"/>
                    <measurement group_id="O2" value="14.31" spread="7.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks (visit 2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.64" spread="8.29"/>
                    <measurement group_id="O2" value="7.13" spread="3.97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks (visit 3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.29" spread="6.08"/>
                    <measurement group_id="O2" value="8.49" spread="5.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Markers of Oxidative Stress</title>
        <description>Blood levels of C reactive protein</description>
        <time_frame>Baseline, 4 weeks</time_frame>
        <population>Subjects who completed all three visits</population>
        <group_list>
          <group group_id="O1">
            <title>Active Supplement</title>
            <description>NutraStem, 2 tablets daily, Vitamin D3 (2000 IU), BioVin® (40 mg) and the proprietary blend (900mg).&#xD;
NutraStem: Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.&#xD;
Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
          </group>
          <group group_id="O2">
            <title>Sugar Pill</title>
            <description>The placebo is identical in appearance to the NutraStem® supplement and contains the following ingredients in a Vegi Capsule:&#xD;
MCC200 DICALCIUM PHOSPHATE BROWN LAKE BLEND (SENSIENT # 09127 ) RED DYE DB-088 (COLORCON) MAGNESIUM STEARATE BLUE #1 ALUM LAKE (POWDER)&#xD;
Placebo: Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
          </group>
        </group_list>
        <measure>
          <title>Markers of Oxidative Stress</title>
          <description>Blood levels of C reactive protein</description>
          <population>Subjects who completed all three visits</population>
          <units>ng/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline (visit 1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1695848.62" spread="2084023.54"/>
                    <measurement group_id="O2" value="1843643.43" spread="1391654.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 weeks (visit 3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="873777.84" spread="647730.33"/>
                    <measurement group_id="O2" value="1935423.36" spread="1096810.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>4 weeks</time_frame>
      <desc>Blood pressure is monitored in individuals while exercising (treadmill walking).</desc>
      <group_list>
        <group group_id="E1">
          <title>Active Supplement</title>
          <description>NutraStem, 2 tablets daily, Vitamin D3 (2000 IU), BioVin® (40 mg) and the proprietary blend (900mg).&#xD;
NutraStem: Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.&#xD;
Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
        </group>
        <group group_id="E2">
          <title>Sugar Pill</title>
          <description>The placebo is identical in appearance to the NutraStem® supplement and contains the following ingredients in a Vegi Capsule:&#xD;
MCC200 DICALCIUM PHOSPHATE BROWN LAKE BLEND (SENSIENT # 09127 ) RED DYE DB-088 (COLORCON) MAGNESIUM STEARATE BLUE #1 ALUM LAKE (POWDER)&#xD;
Placebo: Determine whether NutraStem® in combination with an exercise stimulus will cause increased human peripheral blood sample levels of CD34+ and CD133+ adult stem cells and whether these stem cells display more protection against oxidative stress.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>vasovagal response</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Meharvan Singh, PhD</name_or_title>
      <organization>University of North Texas Health Science Center</organization>
      <phone>8177355429</phone>
      <email>meharvan.singh@unthsc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

